What is the role of ibandronate (Boniva) in the treatment of osteoporosis?

Updated: Jan 20, 2021
  • Author: Rachel Elizabeth Whitaker Elam, MD, MSc; Chief Editor: Herbert S Diamond, MD  more...
  • Print
Answer

Ibandronate (Boniva) is another bisphosphonate that can be given orally once a month and is also available as an intravenous formulation that is given every 3 months. Intravenous bisphosphonates are excellent choices for patients intolerant of oral bisphosphonates or for those in whom adherence is an issue. However, ibandronate has not shown efficacy in nonvertebral fractures in clinical trials.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!